Company Filing History:
Years Active: 2022
Title: Innovator Lloyd Malcolm King and His Contributions to Antimalarial Research
Introduction: Lloyd Malcolm King, an accomplished inventor based in Slough, GB, has made significant advancements in the field of pharmaceutical research. He holds a patent for a novel class of compounds aimed at combating malaria, reflecting his commitment to addressing critical health challenges.
Latest Patents: King’s notable patent, titled "Antimalarial hexahydropyrimidine analogues," includes a series of 2-imino-6-methylhexahydropyrimidin-4-one derivatives and 3-imino-5-methyl-1,2,4-thiadiazinane 1,1-dioxide derivatives. These compounds, characterized by being substituted with an arylaminophenyl or heteroarylaminophenyl moiety, have proven to be potent inhibitors of the growth and propagation of malaria parasites in human blood. As such, they hold promise as effective pharmaceutical agents for the treatment of this debilitating disease.
Career Highlights: King is currently employed at UCB Biopharma Srl, where his expertise in drug development contributes to pioneering solutions for infectious diseases. His work demonstrates an intersection of innovative chemistry and practical application in public health.
Collaborations: Throughout his career, Lloyd Malcolm King has collaborated with notable colleagues such as Teresa De Haro Garcia and Martin Alexander Lowe. Their combined expertise in the research arena enhances the potential for groundbreaking discoveries in the fight against malaria and other infectious diseases.
Conclusion: Lloyd Malcolm King’s pioneering work and patent for antimalarial hexahydropyrimidine analogues exemplify the vital role of inventors in the advancement of medical science. His dedication to innovation, alongside his collaborative efforts, continues to drive forward crucial research needed in the ongoing battle against malaria, making significant contributions to global health.